2020
DOI: 10.1177/1179546820953415
|View full text |Cite
|
Sign up to set email alerts
|

Neurogenic Orthostatic Hypotension: State of the Art and Therapeutic Strategies

Abstract: Neurogenic orthostatic hypotension (nOH) is a subtype of orthostatic hypotension in which patients have impaired regulation of standing blood pressure due to autonomic dysfunction. Several primary and secondary causes of this disease exist. Patients may present with an array of symptoms making diagnosis difficult. This review article addresses the epidemiology, pathophysiology, causes, clinical features, and management of nOH. We highlight various pharmacological and non-pharmacological approaches to treatment… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
17
0
4

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(21 citation statements)
references
References 100 publications
(236 reference statements)
0
17
0
4
Order By: Relevance
“…비신경성기립저혈압이 심박출량(cardiac output) 감소와 혈관수축 (vasoconstriction) 부전으로 인해 발생하는 데 비해 신경성기립저 혈압은 자율신경부전에 의해 교감신경계 자극에 따른 노르에피네 프린(norepinephrine) 분비가 충분하지 않으면서 발생한다 [35].…”
Section: 신경성기립저혈압unclassified
See 3 more Smart Citations
“…비신경성기립저혈압이 심박출량(cardiac output) 감소와 혈관수축 (vasoconstriction) 부전으로 인해 발생하는 데 비해 신경성기립저 혈압은 자율신경부전에 의해 교감신경계 자극에 따른 노르에피네 프린(norepinephrine) 분비가 충분하지 않으면서 발생한다 [35].…”
Section: 신경성기립저혈압unclassified
“…신경성기립저혈압도 크게 일차자율신경부전(primary autonomic dysfunction)이 발생하는 질환들과 다른 질환들에 의해 이차적으 로 발생하는 것으로 나눌 수 있다(Table 3) [25,29,35]. [41].…”
Section: 신경성기립저혈압unclassified
See 2 more Smart Citations
“…Initial strategies should focus on reversible factors such as culprit medications, treatment of comorbidities, and patient education on conservative therapies [ 3 - 5 ]. In any case, treatment goals should be individually tailored to patients and may require multiple pharmacologic treatments to achieve symptomatic relief [ 5 ]. Herein, we present a case of an 81-year-old male with ischemic cardiomyopathy who presented to our hospital with syncope and required a multimodal treatment regimen to treat his severe symptomatic OH.…”
Section: Introductionmentioning
confidence: 99%